Cardiovascular outcomes with antihypertensive therapy in type 2 diabetes: an analysis of intervention trials
JOURNAL OF HUMAN HYPERTENSION（2015）
Abstract
In studies of antihypertensive therapy, relative cardiovascular (CV) risk reduction is largely independent of attained systolic blood pressure (SBP). How this translates to absolute risk reduction (ARR) in diabetes is not clear. We have compared 5-year CV outcomes in 10 studies of intensive versus moderate or active versus placebo therapy in subjects with type 2 diabetes and attained SBPMore
Translated text
Key words
JHH, hypertension, blood pressure, clinical medicine, cardiovascular disease, cardiovascular medicine, human hypertension
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined